A Study Visit Report: Unpacking Thailand’s Medicine Pricing, Reimbursement Policy and Benefits Package

This report summarizes the sessions in the Medicines Pricing, Reimbursement Policy, and Benefits Package for Medicines in Thailand study visit, held on 4 – 8 March 2024 in Nonthaburi, Thailand. This study visit was organized by the Health Intervention and Technology Assessment Program (HITAP) under the aegis of the Ministry of Public Health and supported by the World Health Organization Western Pacific Regional Office (WHO WPRO). The study visit aimed to facilitate knowledge exchange and collaboration among participants.
The report has been prepared by Dimple Butani and Francis Carlo Panlilio from HITAP. We extend our sincere appreciation to all the participants from five countries including Bhutan, Brunei Darussalam, Malaysia, Mongolia and The Philippines for their active participation and engagement throughout the study visit.
Special thanks are also extended to the organizing team, as well as the rapporteurs and facilitators from HITAP, for their invaluable support and assistance in ensuring the smooth and well-coordinated execution of the event.
It is important to note that the findings, interpretations, and conclusions expressed in this report do not necessarily reflect the views of the funding or participating agencies.

Document version: 04 April 2024